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Background The association between depression and an increased risk of death in elderly persons has been established in
both clinical and community studies. Co-occurrence of depression and generalized anxiety has been shown to represent more
severe and more chronic psychopathology. However, little is known about the relation between generalized anxiety disorder,
mixed anxiety-depression (generalized anxiety disorder and depression) and excess mortality in the elderly.
Objective To investigate whether generalized anxiety and mixed anxiety-depression are associated with mortality.
Method Generalized anxiety disorder, mixed anxiety-depression and depression were assessed in 4051 older persons with
a ten-year follow-up of community death registers. The mortality risk of generalized anxiety, depression and mixed anxiety-
depression was calculated after adjustment for demographic variables, physical illness, functional disabilities and social
vulnerability.
Results In generalized anxiety disorder and mixed anxiety-depression no significant excess mortality was found. In
depression a significant excess mortality was found in men [HR 1.44 (1.09–1.89)] but not in women [HR 1.04 (0.87–1.24)]
after adjustment for the different variables.
Conclusions In elderly persons depression increases the risk of death in men. Neither generalized anxiety nor mixed
anxiety-depression are associated with excess mortality. Generalized anxiety disorder may even predict less mortality in
depressive elderly people. The relation between generalized anxiety disorder and its possibly protective effect on mortality
has to be further explored. Copyright # 2006 John Wiley & Sons, Ltd.key words—generalized anxiety disorder; depression; mortalityINTRODUCTION
The association between depression and an increased
risk of death has been firmly established in both
clinical and community studies, in some studies this
association was stronger in men (Penninx et al., 1999;
Schoevers et al., 2000; Blazer et al., 2001; Cuijpers
and Smit, 2002). Compared to studies in depression,
studies on the relation between anxiety and mortality
are sparse. Findings are frequently inconsistent
because of sample differences in co-morbid con-
ditions, socio-economic status and unhealthy life-*Correspondence to: T. J. Holwerda, LASAEMGO,Vrije Universiteit
Medical Centre, Van der Boechorststraat 7, 1081 BT Amsterdam,
The Netherlands. E-mail: tjalling.holwerda@mentrum.nl
Copyright # 2006 John Wiley & Sons, Ltd.styles, which are not controlled for. In a large study
among older persons it was found that, adjusted for
lifestyle variables, demographic characteristics, func-
tional limitations, cognitive functioning and chronic
physical disease, men with anxiety had a mortality risk
of 1.78 (1.01–3.13) while in women no relationship
was found. In this study four anxiety disorders were
included: phobic, panic, generalized anxiety and obse-
ssive–compulsive disorder (Van Hout et al., 2004).
However, no mortality data were reported on specific
anxiety disorders. A general population study showed
that depression but not generalized anxiety is
associated with an increased risk of death (Murphy
et al., 1987). In a large study of 5057 patients referred
to a cardiology department for routine exercise testing,
in which survival data were obtained after five years, itReceived 15 May 2006
Accepted 1 August 2006
242 t. j. holwerda ET AL.was found that symptoms of anxiety and depression
had different predictive effects on mortality. It was
found that, when controlling for physical risks, anxiety
was associated with a lower mortality risk and
depression with a higher mortality risk (Hermann
et al., 2000).
Investigating the relation between (generalized)
anxiety and/or depression and excess mortality is
complicated by the fact that the presence of
(generalized) anxiety is significantly associated
with depression. Onset and offset of (generalized)
anxiety and depression frequently occur at the same
time and recovery rates of (generalized) anxiety and
depression are also related (Castillo et al., 1995;
A˚stro¨m, 1996; Livingston et al., 1997; Beekman
et al., 2000). In the group of anxiety disorders it is
suggested that generalized anxiety disorder in
particular may lie on a continuum with depression.
It may be that the diagnostic categories depression,
generalized anxiety and mixed anxiety depression
may represent the same disorder at a different level
of severity or at a different stage of development
(Liebowitz et al., 1990; Schoevers et al., 2005). In
comparison with either depression or generalized
anxiety, the co-occurrence of depression and
generalized anxiety represents more severe and
more chronic psychopathology. Moreover, remis-
sion rates for depression and co-existing generalized
anxiety are lower in comparison with ‘pure’
depression or ‘pure’ generalized anxiety disorder.
Generalized anxiety often progresses to depression
or depression with generalized anxiety disorder,
suggesting a pattern of temporal sequencing
(Schoevers et al., 2003; Schoevers et al., 2005).
However, it has also been suggested that, although
high levels of co-morbidity between depressive
disorders and anxiety disorders have been found,
anxiety disorders and depressive disorders merit
separate study because risk factors reveal more
differences than similarities (Beekman et al., 2000).
Also was found that generalized anxiety disorder
and major depressive disorder tend to have a
different onset and remission of the disorders. This
further supports the distinction of late life gener-
alized anxiety from major depressive disorder
(Lenze et al., 2005). Finally different neurobiolo-
gical mechanisms in generalized anxiety and
depression indicate a biological distinction between
generalized anxiety and depression (Nutt, 2001).
On the basis of these observations we were
interested in investigating the relation between
generalized anxiety, depression and excess mortality.
The main objectives of our study were to:Copyright # 2006 John Wiley & Sons, Ltd.1. assess whether generalized anxiety disorder is
associated with excess mortality in older persons
in the community;2. assess whether this association, if present, is modi-
fied by co-morbid depression and;3. assess whether this association, if present, is modi-
fied by sex and other explanatory and confounding
factors.METHODS
Sample and non-response
The Amsterdam Study of the Elderly (AMSTEL) is a
longitudinal study of a large and representative sample
of non-institutionalised community living older
persons on mental health problems, medical diagnoses
and demographic characteristics. The sampling and
data collection procedures have been described
elsewhere (Launer et al., 1993; Schoevers et al.,
2000, 2003). In short, the lists of 30 general practices
were used as a sampling frame. Within each practice
respondents were randomly selected from four age
strata spanning five years each (65–69 to 80–84).
The population base for AMSTEL included almost all
the non-institutional individuals in the age bracket of
65–84 who lived in the city of Amsterdam. The study
sample corresponded to the Amsterdam population in
terms of age and gender. An age-stratified sample was
drawn. Four thousand and fifty-one subjects (71.5%)
responded, gave informed consent and were inter-
viewed at baseline. Non-response in the younger old
(<75) was associated with poor performance on
cognitive tests and with health problems. In the older
old (>75) no correlates of non-response were found
(Launer et al., 1994). In 2001, data on vital status were
obtained from the community registers. This enabled
studying the association between generalized anxiety
(ANX), depression (DEP), mixed anxiety-depression
(ANXDEP) and mortality. The study was approved by
the Medical Ethical Committee of the Vrije Uni-
versiteit Amsterdam.
The study sample consisted of all subjects at
baseline (n¼ 4051); excluding those who had an
organic disorder at baseline (n¼ 261) the total number
was 3790.
Measures
A 1-h interview, administered during home visits by
specially trained and regularly supervised inter-
viewers, was held to gather information on psychiatric
symptoms, demographic and medical status. TheInt J Geriatr Psychiatry 2007; 22: 241–249.
DOI: 10.1002/gps
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Mini Mental State Examination (Folstein et al., 1975),
all geriatric Mental State Examination-items related to
organic, affective and anxiety syndromes (Copeland
et al., 1986), the activities of daily living (ADL) scale
(Katz et al., 1963), the Instrumental Activities of Daily
Living (IADL) scale (Lawton and Brody, 1969) and
the CAMDEX-interview (Roth et al., 1986). GMS-
AGECAT generates both syndrome levels (in our
study generalized anxiety disorder, depression and
organic) and hierarchically defined diagnostic levels,
levels represent increasing severity of the disorder,
with case level 5 indicating the most severe end of the
spectrum. Case levels 1 and 2 are classified as
subcases whereas levels 3–5 have been proven valid to
detect cases requiring clinical attention in the
community (Copeland et al., 1986; Copeland et al.,
1987; Copeland et al., 1992). Cognitive status was
assessed by MMSE. The interview was administered
during home visits by lay interviewers who were
specially trained using video sessions and were
regularly supervised.
Psychopathology. Diagnoses of ANX, DEP and
ANXDEP were made according to the GMS-
AGECAT system (Copeland et al., 1986, 1988).
The syndrome levels of ANX and DEP cases at
baseline were defined as AGECAT level 3 or higher. If
subjects had both diagnoses they were classified as
ANXDEP, defined as both level three on generalized
anxiety and depression.
Demographic variables, environmental variables and
physical health. Potentially confounding sociodemo-
graphic factors were sex, age and level of education.
Educational status was dichotomized in lower
(primary school or less) and higher (more than
primary school) education. Environmental vulner-
ability factors were marital status and social support.
Social support was ascertained by the question: ‘Do
you get help from your children, neighbours or other
acquaintances?’ Physical health variables were car-
diovascular and cerebrovascular disease, cancer, lung
disease, diabetes, Parkinson’s disease, arthritis, epi-
lepsy, cognitive status and functional disability.
Chronic diseases were assessed with the CAMDEX
questions on these diseases. Cognitive status was
assessed by MMSE score. Subjects were considered to
have functional disability if their ADL or IADL scores
were two or more points below the maximum score on
the respective scales.Copyright # 2006 John Wiley & Sons, Ltd.Mortality. The follow-up for recording deaths
extended from baseline until the first of January
2001, a follow-up period of 10 years with an average
follow-up of 117.8 months, ranging from 109.2–127.2
months. The dates of death were ascertained through
the registers of the municipality of Amsterdam or the
municipalities where subjects had moved during the
study period.
Data analysis
Baseline sample characteristics are compared between
men and women (Table 1). Differences between men
and women were calculated using chi-square stat-
istics.
Bivariate associations. First odds ratio’s using chi
square statistics [95% Confidence Intervals (CI)] were
calculated for all risk factors potentially associated
with mortality in the whole sample and for men and
women separately (Table 2). A Kaplan-Meyer curve
was further used to examine the association between
ANX, DEP, ANXDEP and mortality (Figure 1).
Multivariate associations. Cox proportional hazard
regression models (Table 3) were used to further
examine the association between ANX, DEP,
ANXDEP and mortality. The effect of ANX, DEP
and ANXDEP on mortality was studied with
successive adjustment for potential confounding
factors (demographic variables, environmental vari-
ables and physical health) and for men and women
separately. Sex differences were tested by adding the
interacting term intersex (depression sex) to the
model.
RESULTS
Sample characteristics
The overall prevalences of ANX, DEP and ANXDEP
were 3.2%, 12.9% and 1.9% respectively. The total
prevalence of ANXwas found to be 2.8 times higher in
women than in men. For DEP this was 2.2 times higher
in women, for ANXDEP this was 5.4 times. In
bivariate analysis, men and women differed on most
disease variables. Men had more myocardial infarc-
tion, lung disease and Parkinson’s disease; women had
more arthritis and diabetes. Functional disabilities
were more common in women. The majority of men
were married, whereas the majority of women were
not married. More women than men had ANX, DEPInt J Geriatr Psychiatry 2007; 22: 241–249.
DOI: 10.1002/gps
Table 1. Baseline sample characteristics for men and women
Variables All Men Women Statistics
(n, %) (n, %) (n, %) (Chisq/df/p)
N 4051 1523 2528
Organic ns
261 (6.4) 85 (5.6) 176 (7.0)
ANX 35.5/1/***
128 (3.2) 16 (1.1) 112 (4.4)
DEP 78.6/1/***
523 (12.9) 105 (6.9) 418 (16.5)
ANXDEP 26.6/1/***
76 (1.9%) 7 (0.5%) 69 (2.7)
Age 23.3/3/***
65–69 836 (20.6) 350 (23.0) 486 (19.2)
70–74 974 (24.0) 396 (26.0) 578 (22.9)
75–79 1050 (25.9) 389 (25.5) 661 (26.1)
80–86 1191 (29.4) 388 (25.5) 803 (31.8)
Education 79.9/1/***
>primary school 2335 (57.6) 1014 (66.6) 1321 (52.3)
Primary school or < 1716 (42.4) 509 (33.4) 1207 (47.7)
Myocardial infarction 53.7/1/***
416 (10.3) 225 (14.8) 191 (7.6)
Stroke ns
230 (5.7) 95 (6.2) 135 (5.3)
Cancer ns
449 (11.1) 154 (10.1) 295 (11.7)
Lung disease 26.5/1/***
663 (16.4) 308 (20.2) 355 (14.0)
Arthritis 99.6/1/***
694 (17.1) 145 (9,5) 549 (21.7)
Diabetes 3.9/1/*
360 (8.9) 118 (7.7) 242 (9.6)
Epilepsy ns
70 (1.7) 26 (1.7) 44 (1.7)
Parkinson 4.5/1/*
59 (1,5) 30 (2.0) 29 (1.1)
MMSE 12.1/2/**
26–30 3281 (81.0) 1274 (83.7) 2007 (79.4)
22–25 522 (12.9) 163 (10.7) 359 (14.2)
0–21 248 (6.1) 86 (5.6) 162 (6.4)
ADL disability 10.5/1/**
325 (8.0) 95 (6.2) 230 (9.1)
IADL disability 33.2/1/***
1039 (25.6) 313 (20.6) 726 (28.7)
Marital status (y) 559.4/1/***
1970 (48.7) 1105 (72.6) 865 (34.2)
Social support (y) 58.4/1/***
842 (20.8) 221 (14.5) 621 (24.6)
Chi-square test for differences between men and women, *p< 0.05, **p< 0.01, ***p< 0.001, ns¼ not significant; p> 0.05.
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.000 (Chi-square/df/p), Table 1)].
Associations of risk factors with mortality
At follow-up after ten years, 2095 (51.7%) subjects
had died during the study period: 60.2% of the men
and 46.6% of the women.Copyright # 2006 John Wiley & Sons, Ltd.Bivariate analysis of baseline characteristics (dece-
ased or alive on 1 January 2001), showed that all risk
factors, except ANX (in both sexes), ANXDEP (in both
sexes), arthritis (in women) and epilepsy (in both sexes),
were associated with excess mortality (Table 2), 51.4%
(66.7% of men and 48.1% of women) of subjects with
ANX had died at follow up. In DEP this was 56.8%
(80.8% of men and 49.7% of women). In ANXDEP this
was 50.7 (66.7 for men and 47.8 for women).Int J Geriatr Psychiatry 2007; 22: 241–249.
DOI: 10.1002/gps
Table 2. Bivariate associations of risk factors with mortality in the full sample and in men and women seperately
Mortality All% OR Men% OR Woman% OR
ALL 50.0 (N¼ 1873) 58.9 (N¼ 840) 44.5 (N¼ 1033)
ANX 52.3 1.15 (0.63–2.08) 75.0 2.23 (0.49–11.07) 47.2 1.19 (0.61–2.30)
DEP 59.0 1.51 (1.22–1.87) 81.7 3.31 (1.87–5.86) 52.9 1.49 (1.17–1.90)
ANXDEP 50.7 1.08 (0.66–1.75) 66.7 1.48 (0.27–8.13) 49.2 1.29 (0.77–2.14)
Age
65–69 28.1 0.31 (0.26–0.37) 37.8 0.32 (0.25–0.41) 21.1 0.26 (0.21–0.34)
70–74 37.0 0.50 (0.43–0.58) 44.9 0.46 (0.36–0.58) 31.6 0.49 (0.40–0.60)
75–79 55.6 1.36 (1.17–1.57) 68.1 1.68 (1.31–2.17) 48.4 1.24 (1.03–1.49)
80–86 73.2 3.91 (3.34–4.58) 85.6 5.85 (4.24–8.08) 67.0 3.77 (3.12–4.55)
Education
>Primary school 46.3 1.44 (1.26–1.64) 54.7 1.77 (1.40–2.24) 39.9 1.50 (1.28–1.77)
Primary school or < 55.4 68.1 50.0
Myocardial infarction 47.9 2.34 (1.87–2.94) 57.1 1.73 (1.26–2.37) 42.7 2.68 (1.94–3.72)
(no/yes) 68.3 69.7 66.7
Stroke 49.0 2.23 (1.65–3.02) 57.8 2.37 (1.42–3.96) 43.6 2.12 (1.44–3.11)
(no/yes) 68.2 76.5 62.1
Cancer 49.1 1.39 (1.13–1.71) 57.9 1.57 (1.08–2.27) 43.6 1.37 (1.07–1.77)
(no/yes) 57.2 68.3 51.5
Lung disease 48.0 1.64 (1.37–1.95) 56.3 1.78 (1.35–2.35) 43.3 1.41 (1.11–1.78)
(no/yes) 60.2 69.6 51.9
Arthritis 49.6 1.09 (0.92–1.29) 58.1 1.48 (1.01–2.15) 43.6 1.18 (0.97–1.44)
(no/yes) 51.8 67.2 47.7
Diabetes 48.3 2.19 (1.72–2.78) 57.6 2.21 (1.42–3.44) 42.6 2.31 (1.73–3.09)
(no/yes) 67.2 75.0 63.1
Epilepsy 49.8 1.63 (0.94–2.82) 58.8 1.52 (0.57–4.01) 44.3 1.76 (0.90–3.43)
(no/yes) 61.8 68.4 58.3
Parkinson 49.5 6.86 (3.09–15.22) 58.4 5.71 (1.71–19.04) 44.0 7.31 (2.52–21.20)
(no/yes) 87.0 88.9 85.2
MMSE
26–30 47.0 0.43 (0.35–0.52) 56.5 0.40 (0.28–0.58) 40.9 0.40 (0.32–0.51)
22–25 64.7 2.00 (1.63–2.44) 74.7 2.20 (1.49–3.25) 60.2 2.09 (1.64–2.66)
0–21 82.6 4.88 (2.79–8.55) 84.4 3.85 (1.47–10.05) 81.5 5.69 (2.85–11.35)
ADL disability 48.2 3.26 (2.44–4.37) 57.2 12.18 (4.41–33.63) 42.5 2.89 (2.10–3.99)
(no/yes) 75.2 94.2 68.1
IADL disability 42.9 3.88 (3.27–4.60) 53.8 4.23 (2.98–6.00) 35.4 4.43 (3.62–5.42)
(no/yes) 74.4 83.1 70.8
Marital status 46.9 1.28 (1.12–1.45) 55.1 1.87 (1.45–2.40) 36.2 1.68 (1.42–2.01)
(yes/no) 53.0 69.6 48.9
Social support 46.2 2.20 (1.86–2.60) 56.0 2.72 (1.91–3.87) 39.4 2.40 (1.97–2.93)
(no/yes) 65.4 77.6 61.0
Deceased or alive on 1 January 2001.
% deceased of baseline category, odds ratio with 95% confidence interval, *reference category, significant OR bold.
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no association with excess mortality; no difference
was found between men and women. Also ANXDEP
was not associated with excess mortality whereas DEP
showed an effect onmortality. The effect of depression
was more pronounced in men [(Kaplan Meyer survival
plot, log rank test: ANX .00/1/.99, DEP15.76/1/
0.0001, ANXDEP .00/1/0.95 (Chi sq/df/p)].
In stepwise hierarchical regression using the Cox
proportional hazards model with adjustment for
potential confounding and explanatory variables
both ANX and ANXDEP were not associated withCopyright # 2006 John Wiley & Sons, Ltd.survival. The unadjusted hazard ratio for ANX was
1.02 (0.67–1.54) for all, 1.29(0.58–2.88) for men and
1.08 (0.67–1.74) for women. In ANXDEP this was
1.05 (0.74–1.47) for all, 1.39(0.52–3.72) for men and
1.19(0.83–1.72) for women. In DEP this was
1.36(1.19–1.56) for all, 2.35(1.83–3.02) for men
and 1.33(1.13–1.58) for women yielding a significant
difference between the sexes in DEP. Sex difference in
DEP was statistically significant (p< 0.001 unad-
justed) and 0.05 (adjusted). In women DEP lost
significance after adjustment for the different vari-
ables (results DEP shown in Table 3).Int J Geriatr Psychiatry 2007; 22: 241–249.
DOI: 10.1002/gps
Figure 1. Kaplan-Meyer survival curve for generalized anxiety disorder, mixed generalized anxiety-depression and depression
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This study was performed to establish the relationship
between generalized anxiety disorder, depression and
mixed anxiety-depression and excess mortality in
older persons living in the community. Due to the large
sample size, the long follow up period and the
incorporation of a wide range of other risk factors
influencing mortality, this study was suitable to
perform this task. Attention was paid to gender
differences based on earlier investigations showing
differential associations in men and women.
Main findings
The overall prevalence of generalized anxiety disorder
was 3.2%. This is in line with prevalences found in
earlier studies in community living elderly (Flint,Table 3. Hazard ratios for depression in the full sample and in me
confounders and explanatory variables
Depression vs none (n vs n)
Hazard ratio All (455 vs 3291)
Unadjusted ratio 1.36 (1.19–1.56)
Adjustment for:
Age/education 1.27 (1.10–1.46)
Myocardial infarction/stroke 1.26 (1.10–1.45)
Other diseases 1.18 (1.02–1.36)
MMSE 1.14 (0.99–1.31)
ADL, IADL disability 1.03 (0.89–1.19)
Marital status/Social support 1.05 (0.90–1.21)
Cox proportional hazards model, 95% C.I., results generalized anxiety
text; significant HR bold.
Copyright # 2006 John Wiley & Sons, Ltd.2005). Similarly, the overall prevalence of depression
(12.9%) was in line with what has been found in other
studies of depression in community-living elderly
(Beekman et al., 1999). 1.9% in our study had both
ANX and DEP.
Also in line with the literature (Beekman et al.,
1998; Schoevers et al., 2000) prevalences in women
were significantly higher than those in men. In
depression, a large proportion of depressed men had
died after ten years follow-up whereas in women this
proportion was clearly lower but still considerable. In
generalized anxiety and mixed anxiety depression
there was no significant excess mortality compared
with subjects without generalized anxiety and mixed
anxiety-depression.
The unadjusted odds ratios showed generalized
anxiety and mixed anxiety–depression not to influencen and women seperately with successive adjustment for potential
Men (88 vs 1337) Women (367 vs 1954)
2.35 (1.83–3.02) 1.34 (1.13–1.58)
2.26 (1.76–2.91) 1.28 (1.08–1.51)
2.07 (1.61–2.68) 1.29 (1.09–1.52)
1.79 (1.38–2.33) 1.20 (1.007–1.42)
1.77 (1.36–2.30) 1.16 (0.97–1.37)
1.51 (1.15–1.97) 1.04 (0.87–1.24)
1.44 (1.09–1.89) 1.04 (0.87–1.24)
vs none and depression-generalized anxiety vs none are reported in
Int J Geriatr Psychiatry 2007; 22: 241–249.
DOI: 10.1002/gps
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this finding did not change. Generalized anxiety and
mixed anxiety depression were not associated with
excess mortality. The finding that (generalized)
anxiety is not associated with mortality is consistent
with earlier findings showing that generalized anxiety
is not associated with a higher mortality risk (Murphy
et al., 1987).
Other studies found an increased mortality risk for
anxiety disorders in men but not in women (Van Hout
et al., 2004). However, in this study the mortality risk
was ascertained for all anxiety disorders whereas in
our study specific generalized anxiety was investi-
gated. Especially panic disorder has been shown to be
associated with high mortality rates in men due to
cardiovascular and cerebrovascular events (Weissman
et al., 1990). Also, phobic anxiety has been shown to
be associated with an increased cardiac risk in some
populations (Haines et al., 1987). Possibly these
different findings in literature may be explained by the
differences in anxiety populations.
In depression, the unadjusted odds ratio was
associated with mortality in both men and women.
This is consistent with our earlier findings (Schoevers
et al., 2000). Depression in women did not predict
mortality when adjusted for other variables related to
mortality.
In the current study generalized anxiety and mixed
anxiety – depression are not associated with excess
mortality. Our data show that generalized anxiety
possibly has a protective effect on mortality in
depressed elderly whereas depression is associated
with a higher mortality risk in men.
Methodological considerations
Limitations. A first limitation is that numbers of cases
were relatively small compared with control cases,
especially in men with generalized anxiety and mixed
anxiety-depression. Earlier data have also shown that
anxiety disorders (and generalized anxiety) in men are
less prevalent than in women (Beekman et al., 1998).
Second: selection bias may have affected the validity
of the study population because elderly persons living
in institutions were excluded. Ethnic minority groups
and immigration populations may be underrepresented
because people not sufficiently able to speak Dutch to
understand the questions of the GMS-AGECAT inter-
view were excluded. Generalization to rural popu-
lations may also be difficult as our sample is of people
living in the city of Amsterdam. In the Netherlands
rural populations generally have lower levels of
psychopathology (Peen and Dekker, 2004).Copyright # 2006 John Wiley & Sons, Ltd.Finally with our data it is difficult to disentangle
cause and effect. We did not study the mechanisms
responsible for the association between psychopathol-
ogy and mortality; also we were not able to study
causes of death. Even though a relatively large number
of potential predictors of mortality were investigated
in multivariate analyses, it remains possible that
certain confounders were not identified.
Strengths. The strength of our study is a long follow-
up period with diagnoses on generalized anxiety,
depression and mixed anxiety-depression in a large
general population sample with largely complete
mortality data.
Explanations
Generalized anxiety has been suggested to have a
positive influence on patients’ illness behaviour.
Evidence has also shown that nonphobic anxiety will
get patients to see their doctors more frequently.
Furthermore, anxious patients may bemore inclined to
receive additional examinations, for example they are
more likely to receive coronary angiography even in
the presence of less severe or insignificant coronary
disease. This could facilitate earlier diagnosis and
initiation of adequate treatment and counteract the
effect of depression (Schocken et al., 1987; Hermann
et al., 2000).
In contrast, panic disorder is associated with more
suicidal ideations and suicide attempts and its risk of
suicide attempts is found to be comparable with that in
major depression (Weissman et al., 1989; Johnson
et al., 1990). Moreover there is evidence of an
association between panic disorder and cardiovascu-
lar/cerebrovascular events (Weissman et al., 1990).
With respect to depression it has long been pointed
out that untreated depressed subjects tend to be worse
in health and are more likely to die from accidents or
suicide (Malzberg, 1937; Tsuang et al., 1978; Cuijpers
and Smit, 2002). In addition, depression may have
adverse effects on endocrine, neurologic and immune
processes and may interfere with the patient’s
motivation toward recovery and compliance with
treatment (Cuijpers and Smit, 2002; Cuijpers and
Schoevers, 2004). Furthermore, depression may act
on mortality through multiple relatively independent
pathways, which pathways may lead to double
feedback loops. For example: depression is known
to increase the likelihood of functional impairment,
and functional impairment in turn, is a risk factor
for depression (Penninx et al., 2000; Blazer et al.,
2001).Int J Geriatr Psychiatry 2007; 22: 241–249.
DOI: 10.1002/gps
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Earlier research suggested that the whole cluster of
anxiety disorders, like depression, is associated with
excess mortality in older persons. To our knowledge,
this is the first study in the elderly in a general
population that especially investigated generalized
anxiety disorder in relation to mortality, and this did
not yield such an association. If replicated, our
findings suggest that generalized anxiety may influ-
ence the course of depression but not mortality. A
possible explanation is that patients seek help in an
earlier stage. However, different neurobiological
mechanisms in generalized anxiety and depression
may also explain this possible difference. Generalized
anxiety should therefore be distinguished from other
anxiety disorders and depression when studying
mortality risk.
In contrast, generalised anxiety was also found to be
associated with both depression severity and an
untoward course of depression (Schoevers et al.,
2005). It is intriguing that generalized anxiety thus
appears to have a differential effect on different
depression outcome parameters. The nature of this
pattern remains to be elucidated.
The next steps for research would be to further
investigate:1. tCohe role of generalized anxiety and other anxiety
disorders in their effect on survival;2. the mechanisms behind the possibly different
pathophysiology of depression and (generalized)
anxiety in relation to survival; and3. the possible differences in help seeking behaviour
in patients with depression and generalised anxiety
disorder.
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